Terns Pharmaceuticals (TERN) News Today $7.99 -0.44 (-5.22%) Closing price 04:00 PM EasternExtended Trading$7.99 0.00 (0.00%) As of 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TERN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Terns Pharmaceuticals (NASDAQ:TERN) Sets New 12-Month High - What's Next?October 6 at 11:29 AM | marketbeat.comMizuho Securities Sticks to Their Buy Rating for EyePoint Pharmaceuticals (EYPT)October 5 at 6:32 PM | theglobeandmail.comTerns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)October 2, 2025 | globenewswire.comTerns Pharmaceuticals: Valued As If It Can't WinSeptember 30, 2025 | seekingalpha.comExchange Traded Concepts LLC Grows Stock Position in Terns Pharmaceuticals, Inc. $TERNSeptember 24, 2025 | marketbeat.comGoldman Sachs Group Inc. Has $1.15 Million Stock Position in Terns Pharmaceuticals, Inc. $TERNSeptember 22, 2025 | marketbeat.comTerns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Average Recommendation of "Moderate Buy" by AnalystsSeptember 22, 2025 | marketbeat.com2 Under-the-Radar Stocks That Could SoarSeptember 21, 2025 | fool.comTerns Pharmaceuticals (NASDAQ:TERN) Stock Price Down 5.1% - Here's WhySeptember 20, 2025 | marketbeat.comTerns Pharmaceuticals (NASDAQ:TERN) Shares Up 10.3% - Should You Buy?September 19, 2025 | marketbeat.comTerns Pharmaceuticals (NASDAQ:TERN) Upgraded by Barclays to "Strong-Buy" RatingSeptember 19, 2025 | marketbeat.comTerns Pharmaceuticals (NASDAQ:TERN) Shares Gap Up - Should You Buy?September 18, 2025 | marketbeat.comTerns Pharmaceuticals (NASDAQ:TERN) Now Covered by BarclaysSeptember 18, 2025 | marketbeat.comTerns Pharmaceuticals (NASDAQ:TERN) Shares Down 3.5% - Should You Sell?September 14, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Buys New Stake in Terns Pharmaceuticals, Inc. $TERNSeptember 14, 2025 | marketbeat.comTerns Pharmaceuticals, Inc. (TERN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comTrexquant Investment LP Cuts Stake in Terns Pharmaceuticals, Inc. $TERNSeptember 10, 2025 | marketbeat.comInvesco Ltd. Raises Holdings in Terns Pharmaceuticals, Inc. $TERNSeptember 10, 2025 | marketbeat.comObesity Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Rhythm Pharma, Boehringer Ingelheim, D&D Pharmatech, ProQR Therapeutics, Nano Precision ...September 9, 2025 | theglobeandmail.comResearch Analysts Issue Forecasts for TERN Q3 EarningsSeptember 9, 2025 | marketbeat.comTerns Pharmaceuticals, Inc. $TERN Shares Purchased by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comGraham Capital Management L.P. Buys 93,296 Shares of Terns Pharmaceuticals, Inc. $TERNSeptember 8, 2025 | marketbeat.comJump Financial LLC Lowers Stock Holdings in Terns Pharmaceuticals, Inc. $TERNSeptember 8, 2025 | marketbeat.comTerns Pharmaceuticals (NASDAQ:TERN) Receives "Neutral" Rating from HC WainwrightSeptember 6, 2025 | marketbeat.comRussell Investments Group Ltd. Has $78,000 Holdings in Terns Pharmaceuticals, Inc. $TERNSeptember 6, 2025 | marketbeat.comTerns Pharmaceuticals (NASDAQ:TERN) Stock Price Up 7% - Here's What HappenedSeptember 4, 2025 | marketbeat.comTerns Pharmaceuticals, Inc. - TERN-701 Investor Educational Webinar TranscriptSeptember 3, 2025 | seekingalpha.comTerns Pharmaceuticals, Inc. (TERN) Special Call - SlideshowSeptember 3, 2025 | seekingalpha.comDriehaus Capital Management LLC Has $2.11 Million Position in Terns Pharmaceuticals, Inc. $TERNSeptember 3, 2025 | marketbeat.comWellington Management Group LLP Increases Position in Terns Pharmaceuticals, Inc. $TERNSeptember 2, 2025 | marketbeat.comTerns Pharmaceuticals, Inc. $TERN Holdings Boosted by Walleye Capital LLCSeptember 1, 2025 | marketbeat.comNuveen LLC Purchases New Shares in Terns Pharmaceuticals, Inc. $TERNAugust 30, 2025 | marketbeat.comTerns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Consensus Recommendation of "Moderate Buy" by BrokeragesAugust 30, 2025 | marketbeat.comTerns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025August 21, 2025 | globenewswire.comDisappointing competitor oral GLP-1 data an opportunity for Terns, says MizuhoAugust 20, 2025 | msn.comWilliam Blair Has Positive Outlook of TERN FY2025 EarningsAugust 9, 2025 | marketbeat.comTerns Pharmaceuticals (NASDAQ:TERN) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPSAugust 6, 2025 | marketbeat.comTerns (TERN) Q2 Net Loss Narrows 16%August 6, 2025 | fool.comTerns Pharmaceuticals Reports Q2 2025 Financial ResultsAugust 6, 2025 | tipranks.comTerns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatesAugust 5, 2025 | globenewswire.comTerns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)August 4, 2025 | globenewswire.comTerns Pharmaceuticals (TERN) to Release Quarterly Earnings on MondayJuly 28, 2025 | marketbeat.comTerns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesJuly 9, 2025 | marketbeat.comTerns Pharmaceuticals CEO & Director Acquires 98% More StockJuly 4, 2025 | finance.yahoo.comTerns Pharmaceuticals, Inc. (NASDAQ:TERN) CFO Purchases $39,300.00 in StockJune 30, 2025 | marketbeat.comTerns pharmaceuticals CEO Burroughs buys $90k in sharesJune 27, 2025 | investing.comInsider Buying: Terns Pharmaceuticals, Inc. (NASDAQ:TERN) CEO Buys 23,314 Shares of StockJune 25, 2025 | marketbeat.comTerns Pharmaceuticals Presents Promising Phase 1 Data for TERN-601 at ADA 2025 and Completes Enrollment for Phase 2 FALCON Trial - NasdaqJune 24, 2025 | nasdaq.comTerns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American ... - MorningstarJune 24, 2025 | morningstar.comMTerns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific SessionsJune 23, 2025 | globenewswire.com Get Terns Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TERN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TERN Media Mentions By Week TERN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TERN News Sentiment▼0.090.55▲Average Medical News Sentiment TERN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TERN Articles This Week▼43▲TERN Articles Average Week Get the Latest News and Ratings for TERN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Terns Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Organon & Co. News Today Mineralys Therapeutics News Today Alvotech News Today ImmunityBio News Today Bausch Health Cos News Today Catalyst Pharmaceuticals News Today Tarsus Pharmaceuticals News Today IDEAYA Biosciences News Today Beam Therapeutics News Today Cidara Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TERN) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terns Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
